GLP-1 receptor agonists such as semaglutide and tirzepatide are FDA-regulated for chronic weight management in adults with a BMI of 30 or higher, or 27 with a weight-related condition. Las Vegas runs around the clock, and dealers, servers, performers and resort staff working overnight and rotating shifts rarely fit a daytime clinic into their week - even as the job keeps appearance and stamina front of mind. Telehealth works on their clock: a licensed Nevada physician reviews your online assessment under Nevada Revised Statutes §629.515, and compounded medication from an FDA-registered 503B pharmacy ships to your Las Vegas address. Monthly cost runs $199–$379 versus about $1,247 for brand-name Ozempic or Wegovy. Medical Director: Dr. Steven Nguyen, MD, Board-Certified Internal Medicine. Serving Las Vegas ZIP codes: 89101, 89102, 89104, 89109, 89119.
Local clinics serving Meadows Village: Premier Physicians Weight Loss & Wellness, Medi-Slim Weight Loss & Spa and Perpetual Health Group. Many patients compare these in-person options against licensed GLP-1 telehealth — prescribed online, shipped to the door.
For Meadows Village residents, the essentials on weight-loss injections. The right starting point is not the brand but the molecule: understanding GLP-1 vs dual agonist shapes the rest of the decision.
Eligibility rests mostly on BMI and comorbidities: a higher threshold on its own, or a lower one when an associated condition like prediabetes or hypertension is present. Eligibility is not fixed: a patient who is not eligible today may become so if their medical situation changes.
In this state, Nevada Revised Statutes §629.515; the reference body is Nevada State Board of Medical Examiners. Typical dosing: depends on the molecule chosen (semaglutide or tirzepatide) after evaluation. Around Meadows Village in Clark County, 3 weight-management practice(s) are listed locally. Associated brands include Wegovy, Zepbound, Ozempic, Mounjaro.
Often a BMI of 30 or higher, or 27 or higher with a weight-related comorbidity, but only the medical evaluation decides.
The approved molecules (semaglutide, tirzepatide) have a documented safety profile under medical supervision; they require a prescription and monitoring.
The two main ones are semaglutide (GLP-1) and tirzepatide (dual GIP/GLP-1). Tirzepatide shows higher average loss in trials, but the choice depends on tolerance and cost.
Medical Director: Dr. Steven Nguyen, MD, Board-Certified Internal Medicine. Licensed in Nevada. All prescriptions issued under Nevada Revised Statutes §629.515 and supervised by Nevada State Board of Medical Examiners.